These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18786466)

  • 1. [Stimulation quality in IVF].
    Fanchin R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Aug; 37 Suppl 1():S26-9. PubMed ID: 18786466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation.
    Fanchin R; Castelo Branco A; Kadoch IJ; Hosny G; Bagirova M; Frydman R
    Fertil Steril; 2004 Jun; 81(6):1554-9. PubMed ID: 15193476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation.
    Fanchin R; Méndez Lozano DH; Louafi N; Achour-Frydman N; Frydman R; Taieb J
    Hum Reprod; 2005 Mar; 20(3):747-51. PubMed ID: 15618255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining cycle day 7 follicle count with the basal antral follicle count improves the prediction of ovarian response.
    Durmusoglu F; Elter K; Yoruk P; Erenus M
    Fertil Steril; 2004 Apr; 81(4):1073-8. PubMed ID: 15066466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrasonographical predictive factors of ovarian response to stimulation prior to in vitro fertilization].
    Ebrard-Charra S; Reyftmann L; Hédon B; Déchaud H
    Gynecol Obstet Fertil; 2005 Oct; 33(10):762-7. PubMed ID: 16154374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation.
    Fanchin R; Schonäuer LM; Cunha-Filho JS; Méndez Lozano DH; Frydman R
    Semin Reprod Med; 2005 Nov; 23(4):354-62. PubMed ID: 16317624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of some hormonal and ultrasound ovarian reserve tests].
    Vladimirov Ia; Tacheva D; Blagoeva V
    Akush Ginekol (Sofiia); 2003; 42(5):14-20. PubMed ID: 14682007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coordination of follicle antrum: from luteal estradiol to the premenstrual antagonist].
    Fanchin R
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S21-3. PubMed ID: 15643681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography.
    Järvelä IY; Sladkevicius P; Kelly S; Ojha K; Campbell S; Nargund G
    Fertil Steril; 2004 Nov; 82(5):1358-63. PubMed ID: 15533360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography.
    Pellicer A; Ardiles G; Neuspiller F; Remohí J; Simón C; Bonilla-Musoles F
    Fertil Steril; 1998 Oct; 70(4):671-5. PubMed ID: 9797096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of automated and manual follicle monitoring in an unrestricted population of 100 women undergoing controlled ovarian stimulation for IVF.
    Ata B; Seyhan A; Reinblatt SL; Shalom-Paz E; Krishnamurthy S; Tan SL
    Hum Reprod; 2011 Jan; 26(1):127-33. PubMed ID: 21112951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
    Kolibianakis EM; Albano C; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Fertil Steril; 2004 Jul; 82(1):102-7. PubMed ID: 15236997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.